跳至主要内容
临床试验/KCT0008143
KCT0008143招募中未知

The effect of intravenous iron therapy and erythropoesis-stimulation agent combination on renal transplant outcomes : INTERACT study

Yonsei University Health System, Severance Hospital0 个研究点目标入组 302 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
302

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. living donor transplantation (Age >19)
  • 2. Ferririn<700?/L, TSAT<40%

排除标准

  • 1. subject who is CDC(+), FXM(+)
  • 2. Subject with a active infection
  • 3. Hematologic malignancy, monoclonal gammaglobulin Dz, Hematologic Dz induced anemia
  • 4. Receiving treatment of malignant tumor
  • 5. Subject who is HIV(+)
  • 6. Recent(within 3 months) participation in an interventional trial
  • 7. ALT, AST >3 times upper limit of normal

研究者

相似试验

招募中
Unknown
Effect of intravenous iron supplementation on the level of hemoglobin in staged bilateral knee arthroplastyDiseases of the musculoskeletal system and connective tissue
KCT0008823Chonnam National University Hospital Hwasun Hospital120
招募中
不适用
Effect of intravenous iron supplementation on the level of hemoglobin in revision hip and knee arthroplastyDiseases of the musculo-skeletal system and connective tissue
KCT0005832Chonnam National University Hospital Hwasun Hospital120
进行中(未招募)
1 期
Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer.Iron-deficiency in colorectal cancerMedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2019-003819-56-DKCentre for Surgical Science134
招募中
不适用
To study Effect of injectable iron for improving quality of life and mortality in patients with heart failure with reduced ejection fraction with iron deficiency.
CTRI/2022/06/043440PGIMER CHANDIGARH
进行中(未招募)
1 期
Impact of Iron Deficiency treatment with intravenous ferric carboxymaltose in patients with Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease and Iron DeficiencyMedDRA version: 20.0Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2017-003659-52-PTAntónio Robalo Nunes70